FRA
ISRG icon

Front Row Advisors’s Intuitive Surgical ISRG Stock Holding History

Front Row Advisors’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.96M Sell
6,412
-15
-0.2% -$7.59K 1% 28
2025
Q4 		$3.64M Buy
6,427
+55
+0.9% +$29.3K 1.21% 20
2025
Q3 		$2.85M Sell
6,372
-1,057
-14% -$507K 0.96% 25
2025
Q2 		$4.04M Buy
7,429
+79
+1% +$41.3K 1.4% 15
2025
Q1 		$3.64M Hold
7,350
– – 1.4% 15
2024
Q4 		$3.84M Buy
7,350
+5
+0.1% +$2.6K 1.33% 16
2024
Q3 		$3.61M Buy
7,345
+114
+2% +$53.1K 1.29% 19
2024
Q2 		$3.22M Sell
7,231
-838
-10% -$334K 1.12% 18
2024
Q1 		$3.22M Buy
8,069
+28
+0.3% +$10.6K 1.19% 21
2023
Q4 		$2.71M Buy
8,041
+50
+0.6% +$14.9K 1.25% 25
2023
Q3 		$2.34M Buy
7,991
+286
+4% +$89.3K 1.08% 25
2023
Q2 		$2.63M Buy
7,705
+176
+2% +$53.3K 1.17% 21
2023
Q1 		$1.92M Buy
7,529
+603
+9% +$149K 0.92% 31
2022
Q4 		$1.84M Sell
6,926
-220
-3% -$53.6K 0.95% 30
2022
Q3 		$1.34M Sell
7,146
-73
-1% -$15.7K 0.69% 48
2022
Q2 		$1.45M Buy
7,219
+6
+0.1% +$1.41K 0.71% 43
2022
Q1 		$2.18M Buy
7,213
+355
+5% +$104K 0.88% 33
2021
Q4 		$2.46M Buy
6,858
+249
+4% +$85.7K 0.92% 30
2021
Q3 		$2.19M Buy
6,609
+78
+1% +$26.2K 0.92% 31
2021
Q2 		$2.3M Buy
6,531
+603
+10% +$169K 0.94% 30
2021
Q1 		$1.46M Buy
5,928
+321
+6% +$80.8K 0.71% 50
2020
Q4 		$1.53M Buy
5,607
+51
+0.9% +$12.7K 0.78% 43
2020
Q3 		$1.35M Buy
5,556
+18
+0.3% +$4.04K 0.72% 47
2020
Q2 		$1.05M Sell
5,538
-12
-0.2% -$2.15K 0.65% 47
2020
Q1 		$945K Buy
+5,550
New +$1.02M 0.64% 47
2019
Q1 		– Sell
-30
Closed -$5K – 1075
2018
Q4 		$5K Sell
30
-18
-38% -$3.05K ﹤0.01% 537
2018
Q3 		$8 Hold
48
– – 0.01% 459
2018
Q2 		$8 Hold
48
– – 0.01% 487
2018
Q1 		$7K Hold
48
– – ﹤0.01% 495
2017
Q4 		$6K Buy
+48
New +$6.01K ﹤0.01% 510

Other funds holding ISRG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Front Row Advisors's ISRG Position: Q1 2026 in Review

Front Row Advisors reduced its Intuitive Surgical (ISRG) stake by 0.23% in Q1 2026, selling an estimated $7.59K and leaving 6,412 shares worth $2.96M. The position accounts for 1% of the portfolio, ranked #28.

Front Row Advisors first reported a position in ISRG in Q4 2017 and has held it in 30 quarters since. The position peaked at $4.04M in Q2 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Front Row Advisors held 6,412 shares of Intuitive Surgical worth $2.96M as of Q1 2026.
  • Front Row Advisors sold 15 Intuitive Surgical shares in Q1 2026, an estimated $7.59K.
  • Intuitive Surgical made up 1% of Front Row Advisors's portfolio in Q1 2026, its #28 holding.
  • Front Row Advisors first reported a position in Intuitive Surgical in Q4 2017 and has held it in 30 quarters since.
  • Front Row Advisors's Intuitive Surgical position peaked at $4.04M in Q2 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.